ResearcherBeckman Research InstituteActive in the last 2 years
Syed Rahmanuddin
Matched on ORCID iD 0000-0003-2507-8755; OpenAlex author ID A5045207211. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 30
2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 4
- A phase II clinical trial of albumin-bound paclitaxel, cisplatin, gemcitabine (NABPLAGEM), and paricalcitol as neoadjuvant therapy in pancreatic cancer. Co-author DOI 10.1093/oncolo/oyag232↗
- Therapeutic Targeting of Oncogene-Induced Transcription-Replication Conflicts in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2025.02.038↗
- Role of 3D Volumetric and Perfusion Imaging for Detecting Early Changes in Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.678617↗
- Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Ea… Co-author DOI 10.3389/fonc.2020.596931↗
Closest collaborators
The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daniel D. Von Hoff · 3 shared papers, 2020–2026 · strength 0.42
- Paper A phase II clinical trial of albumin-bound paclitaxel, cisplatin, gemcitabine (NABPLAGEM), and paricalcitol as neoadjuv… DOI 10.1093/oncolo/oyag232↗
- Paper Role of 3D Volumetric and Perfusion Imaging for Detecting Early Changes in Pancreatic Adenocarcinoma. DOI 10.3389/fonc.2021.678617↗
- Paper Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pr… DOI 10.3389/fonc.2020.596931↗
- Ronald Lee Korn · 2 shared papers, 2021–2026 · strength 0.33
- Erkut Hasan Borazanci · 2 shared papers, 2021–2026 · strength 0.33
- Vincent M. Chung · 2 shared papers, 2021–2025 · strength 0.31
- Albert Amini · 1 shared paper, 2026 · strength 0.22
- Alexa F. Viniotis · 1 shared paper, 2026 · strength 0.22
- Gayle Jameson · 1 shared paper, 2026 · strength 0.22
- Ronald M. Evans · 1 shared paper, 2026 · strength 0.22
- Shanna J. Smith · 1 shared paper, 2025 · strength 0.20
- Thuy Xuan Phan · 1 shared paper, 2025 · strength 0.20
- Fan Meng · 1 shared paper, 2025 · strength 0.20
- Laleh Golkar Melstrom · 1 shared paper, 2025 · strength 0.20
- Richard A. Burkhart · 1 shared paper, 2025 · strength 0.20
- Toni T. Seppälä · 1 shared paper, 2025 · strength 0.20
- Yilun Liu · 1 shared paper, 2025 · strength 0.20
- Mustafa Raoof · 1 shared paper, 2025 · strength 0.20
- Eugene Jon Koay · 2 shared papers, 2020–2021 · strength 0.19
- Ajay Goel · 2 shared papers, 2020–2021 · strength 0.19
- Derek Cridebring · 1 shared paper, 2021 · strength 0.11
- Michael Hayden Rosenthal · 1 shared paper, 2020 · strength 0.08
- Prashant Dogra · 1 shared paper, 2020 · strength 0.08
- Eric Peter Tamm · 1 shared paper, 2020 · strength 0.08
- Mohamed Zaid · 1 shared paper, 2020 · strength 0.08
- Anil K. Dasyam · 1 shared paper, 2020 · strength 0.08
- Randall E. Brand · 1 shared paper, 2020 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.